PETX
Aratana Therapeutics, Inc.
PETX
PETX
Delisted
PETX was delisted on the 17th of July, 2019.
103 hedge funds and large institutions have $200M invested in Aratana Therapeutics, Inc. in 2019 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 33 increasing their positions, 20 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 104 → 103 (-1)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
103
Holding in Top 10
1
Calls
$442K
Puts
$28K
Top Buyers
1 | +$16M | |
2 | +$14.7M | |
3 | +$14.1M | |
4 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$12.4M |
5 |
OAC
OMERS Administration Corp
Toronto,
Ontario, Canada
|
+$5.21M |
Top Sellers
1 | -$8.7M | |
2 | -$5.73M | |
3 | -$5.69M | |
4 |
JG
Jefferies Group
New York
|
-$5.4M |
5 |
GPGA
Grandeur Peak Global Advisors
Salt Lake City,
Utah
|
-$3.93M |